title: Gamma camera imaging of osseous metastatic lesions by strontium-89 bremsstrahlung.
abstract: The aim of this study was to optimise the parameters affecting the Bremsstrahlung scintigraphy of patients injected with strontium-89 chloride. The parameters considered were : (1) instrumental detection efficiency, and (2) tissue attenuation factor for 89Sr calibrated sources, which permit quantitative evaluation of the activity in a given bone lesion. Some typical examples of in vivo 89Sr imaging are presented to illustrate the clinical utility of the imaging procedure developed by us, which is implemented in our department for all patients treated with 89Sr chloride.
authors.affiliation: Nuclear Medicine Service, S. Eugenio Hospital, Rome, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Cipriani
authors.forename: G
authors.initials: G
authors.lastname: Atzei
authors.forename: G
authors.initials: G
authors.lastname: Argirò
authors.forename: S
authors.initials: S
authors.lastname: Boemi
authors.forename: S
authors.initials: S
authors.lastname: Shukla
authors.forename: G
authors.initials: G
authors.lastname: Rossi
authors.forename: A F
authors.initials: AF
authors.lastname: Sedda
mesh_terms: D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology; D002138:Calibration; D015902:Gamma Cameras; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013326:Strontium Radioisotopes; D013669:Technetium Tc 99m Medronate
chemical_list: D019275:Radiopharmaceuticals; D013326:Strontium Radioisotopes; D013669:Technetium Tc 99m Medronate